ERBB2 and breast cancer: Triple-negative breast cancer, defined by lack of expression of the estrogen and progesterone receptors and absent amplification of the HER2 gene, and the basal-like molecular subtype defined by RNA gene expression have earlier occurrences of metastasis, worsened survival, and fewer therapeutic options compared to other breast cancer subtypes.